Clinical Outcomes Associated With Various Microvascular Injury Patterns Identified by CMR After STEMI

Ivan Lechner1, Martin Reindl1, Thomas Stiermaier2

  • 1University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Insights

Microvascular injury (MVI) after ST-segment elevation myocardial infarction (STEMI) is only linked to adverse outcomes when intramyocardial hemorrhage (IMH) is present. Isolated microvascular obstruction (MVO) shows a similar prognosis to no MVI.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Biomarkers

Background:

  • Prognostic significance of microvascular injury (MVI) patterns post-ST-segment elevation myocardial infarction (STEMI) remains unclear.
  • Understanding MVI's impact is crucial for risk stratification after myocardial infarction.

Purpose of the Study:

  • To investigate the prognostic implications of different microvascular injury (MVI) patterns in STEMI patients.
  • To differentiate outcomes based on the presence of microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH).

Main Methods:

  • Analysis of 1,109 STEMI patients from 3 prospective studies.
  • Cardiac magnetic resonance (CMR) including late gadolinium enhancement and T2* mapping performed post-percutaneous coronary intervention (PCI).
  • Categorization into no MVI (MVO-/IMH-), MVO only (MVO+/IMH-), and IMH (IMH+) groups.

Main Results:

  • MVI observed in 57% of patients; 32% had IMH+ pattern.
  • IMH+ group exhibited larger infarct size and lower ejection fraction compared to MVO+/IMH- and MVO-/IMH- groups.
  • Higher incidence of major adverse cardiovascular events in IMH+ group (19.5%) versus MVO+/IMH- (3.6%) and MVO-/IMH- (4.4%) during 12-month follow-up.

Conclusions:

  • Microvascular injury (MVI) is associated with adverse outcomes exclusively in patients with intramyocardial hemorrhage (IMH+).
  • Patients with only microvascular obstruction (MVO+/IMH-) have a similar prognosis to those without MVI (MVO-/IMH-).
  • Intramyocardial hemorrhage (IMH) is an independent predictor of adverse events, highlighting its prognostic importance post-STEMI.
Abstract